글로벌 로봇 보조 경피적 관상동맥 중재술(PCI) 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

로봇 보조 경피관상동맥중재술(PCI) 시장 분석

로봇 보조 경피적 관상 동맥 중재술(PCI) 시장은 기술 발전과 최소 침습적 시술에 대한 수요 증가에 힘입어 주목할 만한 성장을 경험하고 있습니다. 최근 개발에는 관상동맥 중재술 중 정밀도와 제어력을 향상시키고 회복 시간을 단축하며 환자 결과를 개선하는 정교한 로봇 시스템이 도입되었습니다. 이러한 시스템은 더 큰 손재주와 정확성을 제공하여 심장 전문의가 환자에게 최소한의 불편함을 주면서 복잡한 시술을 수행할 수 있도록 합니다. 관상동맥 질환의 유병률이 증가하고 인구가 고령화되면서 의료 서비스 제공자가 시술 효과를 높이기 위한 혁신적인 솔루션을 모색함에 따라 시장 확장이 더욱 가속화되었습니다. 또한 인공 지능 과 고급 영상 기술을 로봇 시스템에 통합하면 PCI에 혁명이 일어나 실시간 데이터를 제공하고 의사 결정을 개선할 수 있습니다. 병원에서 이러한 기술을 점점 더 많이 도입함에 따라 로봇 보조 PCI 시장은 상당한 성장을 앞두고 있으며 제조업체와 의료 서비스 제공자 모두에게 유망한 기회를 제공합니다.

로봇 보조 경피관상동맥중재술(PCI) 시장 규모

글로벌 로봇 보조 경피적 관상동맥 중재술(PCI) 시장 규모는 2023년에 134억 달러로 평가되었으며, 2031년까지 1,643억 5,000만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 36.80%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

로봇 보조 경피관상동맥중재술(PCI) 시장 동향

“ 로봇 시스템 도입 증가”

로봇 보조 경피적 관상동맥 중재술(PCI) 시장은 의료 기술이 발전함에 따라 혁신적인 추세를 보이고 있습니다. 두드러진 추세 중 하나는 수술 중 외과의의 신체적 부담을 줄이고 정밀도를 높이는 로봇 시스템의 채택이 증가하고 있다는 것입니다. 이러한 시스템은 손재주와 제어력을 개선하여 복잡한 중재를 더 안전하고 효과적으로 만들어줍니다. 심장 전문의가 회복 시간 단축과 시술 위험 감소를 포함한 로봇 보조의 이점을 인식함에 따라 수요가 증가할 것으로 예상됩니다. 또한 이러한 시스템에 인공 지능과 머신 러닝을 통합하면 시술 계획 및 실행이 최적화되어 시장 성장이 더욱 촉진될 것입니다. 로봇 보조 기술로의 이러한 전환은 중재 심장학의 환경을 재편하고 환자에게 더 나은 결과를 약속하며 의료 제공자에게 효율성을 높여줍니다.

보고 범위 및 로봇 지원 경피적 관상동맥 중재술(PCI) 시장 세분화

로봇 보조 경피관상동맥중재술(PCI) 시장 정의

Robot-Assisted Percutaneous Coronary Intervention (PCI) refers to a minimally invasive surgical procedure that employs robotic technology to enhance the treatment of coronary artery disease. During this procedure, a catheter is guided through the blood vessels to reach blocked or narrowed coronary arteries, where interventions such as balloon angioplasty or stent placement can be performed. The use of robotic systems allows for greater precision and dexterity, enabling cardiologists to navigate complex anatomies with improved control. This advanced approach reduces the physical strain on surgeons and enhances patient outcomes by minimizing trauma and recovery times.

Robot Assisted Percutaneous Coronary Intervention (PCI) Market Dynamics

Drivers

• Innovations in Robotic Technology and Advanced Imaging Systems

Innovations in robotic technology and advanced imaging systems serve as a key market driver for Robot-Assisted Percutaneous Coronary Intervention (PCI) by significantly enhancing procedural precision. This improvement leads to better patient outcomes, which in turn drives demand for these advanced techniques. With cutting-edge technologies, cardiologists can perform complex procedures with greater accuracy, effectively reducing the risk of complications commonly associated with traditional methods. Enhanced imaging techniques provide real-time visualization of the coronary anatomy, allowing for improved navigation and intervention. As a result, patients benefit from shorter recovery times, reduced pain, and lower rates of adverse events. The combination of precision robotics and sophisticated imaging optimizes procedural effectiveness and boosts healthcare provider confidence, further increasing the preference for robotic-assisted approaches in interventional cardiology.

• Rising Incidence of Coronary Artery Disease

The rising incidence of coronary artery disease (CAD), especially among aging populations, significantly boosts the demand for effective treatment options such as robot-assisted percutaneous coronary intervention (PCI). As the global population ages, the prevalence of risk factors such as hypertension, diabetes, and high cholesterol increases, leading to a higher rate of CAD. This growing health concern underscores the need for advanced interventions that can provide precise and minimally invasive treatment options. Robot-assisted PCI offers significant advantages, including reduced recovery times and lower complication rates, making it an attractive choice for both patients and healthcare providers. As awareness of CAD rises and the population ages, the demand for innovative solutions like robot-assisted PCI is expected to escalate, driving market growth.

Opportunities

• Expansion into Emerging Markets

With healthcare infrastructure improves in emerging economies, the potential for adopting robotic-assisted technologies in medical procedures, including Robot-Assisted Percutaneous Coronary Intervention (PCI), is substantial. These advancements often include better training programs for healthcare professionals, enhanced surgical facilities, and increased availability of advanced medical equipment. With rising investment in healthcare and a growing awareness of the benefits of minimally invasive procedures, hospitals in these regions are more inclined to adopt robotic systems. This shift not only improves patient outcomes through reduced recovery times and fewer complications but also enhances the overall quality of care. Consequently, the expansion of robotic-assisted technologies in emerging markets represents a significant opportunity for manufacturers to broaden their market reach and establish a stronger foothold in the global healthcare landscape.

• Opportunities for Integrating Advanced Technologies

Opportunities for integrating advanced technologies, such as artificial intelligence (AI) and machine learning, into robotic systems are transforming the landscape of robot-assisted percutaneous coronary intervention (PCI). Robotic systems can analyze vast amounts of data to provide real-time insights and predictive analytics during procedures by harnessing AI algorithms. This integration enhances procedural capabilities by improving accuracy in navigation and intervention, allowing for more precise targeting of affected areas. In addition, machine learning can facilitate continuous improvement of robotic systems by adapting to individual patient anatomy and procedural outcomes over time. Such advancements optimize performance and support healthcare professionals in making more informed decisions, ultimately leading to improved patient outcomes and greater efficiency in interventional cardiology.

Restraints/Challenges

• High Costs Hindering Robotic System Adoption

The significant investment required for robotic systems presents a considerable challenge for hospitals and healthcare facilities, often deterring them from adopting this advanced technology. The initial costs associated with purchasing, installing, and maintaining robotic surgical systems can be prohibitively high, particularly for smaller institutions with limited budgets. This financial burden may lead to hesitancy in investing in robotic-assisted procedures, as facilities weigh the potential benefits against the substantial upfront expenses. Furthermore, ongoing costs related to training staff and ensuring proper usage can further strain financial resources. As a result, many healthcare providers may opt for traditional methods that require less investment, ultimately limiting the growth of the Robot-Assisted Percutaneous Coronary Intervention (PCI) market and the broader adoption of robotic technologies in cardiology.

• Regulatory Challenges Impeding Innovation in Robotic PCI

The lack of skilled professionals poses a significant challenge to the cytomegalovirus (CMV) retinitis market, impacting both diagnosis and treatment outcomes. Effective management of CMV retinitis requires specialized knowledge and expertise, particularly in identifying at-risk populations, interpreting diagnostic tests, and administering appropriate antiviral therapies. However, there is a notable shortage of trained healthcare professionals, including ophthalmologists and infectious disease specialists, particularly in low- and middle-income countries. For instance, the World Health Organization (WHO) estimates a projected shortfall of 10 million health workers by 2030, mostly in low- and lower-middle-income countries. Consequently, shortage of skilled professionals emerges as a significant market challenge, hindering the growth and effectiveness of the CMV retinitis market and compromising patient outcomes.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Robot Assisted Percutaneous Coronary Intervention (PCI) Market Scope

The market is segmented on the basis of component, application, product type and end user.The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Robotic Systems
• Instruments
• Accessories

End User

• Hospitals
• Cath Labs
• Others

Component

• Robotic Systems
• Control Consoles
• Catheters and Guidewires

Application

• Coronary Angioplasty
• Stent Placement
• Thrombectomy

Robot Assisted Percutaneous Coronary Intervention (PCI) Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, component, application, product type and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is anticipated to lead the Robot-Assisted Percutaneous Coronary Intervention (PCI) market, primarily driven by heightened funding for research and development in surgical robotics. This financial support facilitates the innovation and advancement of robotic technologies, enhancing their adoption in clinical settings. As a result, the region is well-positioned to benefit from the latest breakthroughs, further solidifying its dominance in the market.

The Asia-Pacific region is projected to experience the highest growth rate in the Robot-Assisted Percutaneous Coronary Intervention (PCI) market from 2024 to 2031. This surge is driven by increasing awareness of the benefits of minimally invasive surgeries, coupled with rising incidences of health issues linked to unhealthy dietary patterns. In addition, the growing geriatric population in these countries further amplifies the demand for advanced surgical solutions, positioning the region for significant market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Robot Assisted Percutaneous Coronary Intervention (PCI) Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Robot Assisted Percutaneous Coronary Intervention (PCI) Market Leaders Operating in the Market Are:

• Stryker (U.S.)
• Medtronic (U.S.)
• Intuitive Surgical Operations, Inc. (U.S.)
• THINK Surgical, Inc. (U.S.)
• Medical Device Business Services, Inc. (U.S.)
• meerecompany Inc. (South Korea)
• Renishaw plc (U.K.)
• Accuray Incorporated (U.S.)
• Stereotaxis, Inc. (U.S.)
• KUKA AG (Germany)

Latest Developments in Robot Assisted Percutaneous Coronary Intervention (PCI) Market

• 2020년 3월, 심장 부정맥 치료를 위한 선구적 로봇 기술의 글로벌 리더인 Stereotaxis(NYSE: STXS)는 Genesis RMN® 시스템에 대한 FDA 510(k) 허가를 받았다고 발표했습니다. 이 첨단 시스템은 심장 리듬 장애를 해결하기 위해 특별히 설계된 자기 절제 카테터의 로봇 내비게이션을 용이하게 합니다. FDA 허가는 이러한 질환이 있는 환자의 치료 옵션을 개선하려는 Stereotaxis의 사명에 있어 상당한 진전을 의미합니다.

SKU-21784